Embedded Files
Stephen J. Pandol, MD, Professor of Medicine, Cedars-Sinai Medical Center (Los Angeles, CA) serves as Armida Labs Chief Medical Officer. Dr. Pandol has over 30 years of clinical research experience focused on mechanisms of physiology and pathophysiology of the gastrointestinal tract with an emphasis on exocrine pancreatic disorders. His work on pancreatic cancer is focused on mechanisms of metastasis and resistance to therapy. He found that circulating tumor cells are resistant to current therapies so the agents being developed at Armida Labs are highly relevant to develop novel effective therapeutics against pancreatic cancer and other solid tumors. Dr. Pandol is author of nearly 300 peer reviewed publications in the field of transitional clinical cancer biology. The Pandol Laboratory at the Cedars-Sinai Pancreatic Research Program is dedicated to establishing and maintaining the leading international research area at Cedars-Sinai for advancing the prevention, early diagnosis and treatment of pancreatic diseases. Basic and translational research efforts at the Pancreatic Research Program are designed to advance clinical care for cancer patients. The Pandol Laboratory is affiliated with the Pancreatic and Biliary Diseases Program and the Samuel Oschin Comprehensive Cancer Institute.
Stephen J. Pandol, MD, Professor of Medicine, Cedars-Sinai Medical Center (Los Angeles, CA) serves as Armida Labs Chief Medical Officer. Dr. Pandol has over 30 years of clinical research experience focused on mechanisms of physiology and pathophysiology of the gastrointestinal tract with an emphasis on exocrine pancreatic disorders. His work on pancreatic cancer is focused on mechanisms of metastasis and resistance to therapy. He found that circulating tumor cells are resistant to current therapies so the agents being developed at Armida Labs are highly relevant to develop novel effective therapeutics against pancreatic cancer and other solid tumors. Dr. Pandol is author of nearly 300 peer reviewed publications in the field of transitional clinical cancer biology. The Pandol Laboratory at the Cedars-Sinai Pancreatic Research Program is dedicated to establishing and maintaining the leading international research area at Cedars-Sinai for advancing the prevention, early diagnosis and treatment of pancreatic diseases. Basic and translational research efforts at the Pancreatic Research Program are designed to advance clinical care for cancer patients. The Pandol Laboratory is affiliated with the Pancreatic and Biliary Diseases Program and the Samuel Oschin Comprehensive Cancer Institute.
Page updated
Google Sites
Report abuse